Bafna said the brand has already crossed half its monthly sales target in October, driven by festival buying and higher gold prices pushing customers toward lighter lab‑grown jewellery—an unexpected lift for a company that had set an ambitious target.
The CEO added that the average ticket for Indian customers sits around ₹50,000‑₹60,000, with solitaire rings and tennis bracelets leading the pack—an indicator of the segment's premium positioning.
He also highlighted a historic sale of a 50‑carat lab‑grown diamond, signaling growing acceptance among high‑net‑worth buyers, and hinted at expanding beyond metros into Tier‑II and Tier‑III markets.
While the brand projects a 2× topline growth over the next year, Bafna underscored that this will be driven by new store openings and rising awareness of lab‑grown diamonds across India.
Analysts note that the lab‑grown diamond market is still nascent, but the shift toward cost‑effective alternatives amid rising gold prices could accelerate demand, offering a niche for retailers like Akoirah.
No official earnings or stock price data are yet available, but the optimistic outlook may attract investor interest in niche jewellery segments as the sector evolves.